1073 related articles for article (PubMed ID: 20962846)
1. Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling.
Ghoreschi K; Laurence A; Yang XP; Tato CM; McGeachy MJ; Konkel JE; Ramos HL; Wei L; Davidson TS; Bouladoux N; Grainger JR; Chen Q; Kanno Y; Watford WT; Sun HW; Eberl G; Shevach EM; Belkaid Y; Cua DJ; Chen W; O'Shea JJ
Nature; 2010 Oct; 467(7318):967-71. PubMed ID: 20962846
[TBL] [Abstract][Full Text] [Related]
2. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.
Zhou L; Lopes JE; Chong MM; Ivanov II; Min R; Victora GD; Shen Y; Du J; Rubtsov YP; Rudensky AY; Ziegler SF; Littman DR
Nature; 2008 May; 453(7192):236-40. PubMed ID: 18368049
[TBL] [Abstract][Full Text] [Related]
3. Induction of interleukin-10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G-1.
Brunsing RL; Prossnitz ER
Immunology; 2011 Sep; 134(1):93-106. PubMed ID: 21722102
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.
Sutton CE; Lalor SJ; Sweeney CM; Brereton CF; Lavelle EC; Mills KH
Immunity; 2009 Aug; 31(2):331-41. PubMed ID: 19682929
[TBL] [Abstract][Full Text] [Related]
5. IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction.
Prochazkova J; Pokorna K; Holan V
Immunobiology; 2012 Jan; 217(1):74-82. PubMed ID: 21903294
[TBL] [Abstract][Full Text] [Related]
6. Jagged-1 signaling suppresses the IL-6 and TGF-β treatment-induced Th17 cell differentiation via the reduction of RORγt/IL-17A/IL-17F/IL-23a/IL-12rb1.
Wang Y; Xing F; Ye S; Xiao J; Di J; Zeng S; Liu J
Sci Rep; 2015 Feb; 5():8234. PubMed ID: 25648768
[TBL] [Abstract][Full Text] [Related]
7. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo.
Sonderegger I; Kisielow J; Meier R; King C; Kopf M
Eur J Immunol; 2008 Jul; 38(7):1833-8. PubMed ID: 18546146
[TBL] [Abstract][Full Text] [Related]
8. Local inhibition of TGF-β1 signaling improves Th17/Treg balance but not joint pathology during experimental arthritis.
Aarts J; van Caam A; Chen X; Marijnissen RJ; Helsen MM; Walgreen B; Vitters EL; van de Loo FA; van Lent PL; van der Kraan PM; Koenders MI
Sci Rep; 2022 Feb; 12(1):3182. PubMed ID: 35210510
[TBL] [Abstract][Full Text] [Related]
9. [Generation of engineering Th17 cells and its function evaluation].
Zhang HX; Chen C; Zeng LY; Zhang Y; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):825-9. PubMed ID: 22339955
[TBL] [Abstract][Full Text] [Related]
10. TGF-β converts Th1 cells into Th17 cells through stimulation of Runx1 expression.
Liu HP; Cao AT; Feng T; Li Q; Zhang W; Yao S; Dann SM; Elson CO; Cong Y
Eur J Immunol; 2015 Apr; 45(4):1010-8. PubMed ID: 25605286
[TBL] [Abstract][Full Text] [Related]
11. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF.
El-Behi M; Ciric B; Dai H; Yan Y; Cullimore M; Safavi F; Zhang GX; Dittel BN; Rostami A
Nat Immunol; 2011 Jun; 12(6):568-75. PubMed ID: 21516111
[TBL] [Abstract][Full Text] [Related]
12. Optimization of human Th17 cell differentiation in vitro: evaluating different polarizing factors.
Ganjalikhani Hakemi M; Ghaedi K; Andalib A; Hosseini M; Rezaei A
In Vitro Cell Dev Biol Anim; 2011 Sep; 47(8):581-92. PubMed ID: 21853398
[TBL] [Abstract][Full Text] [Related]
13. Microbiota-induced IL-1β, but not IL-6, is critical for the development of steady-state TH17 cells in the intestine.
Shaw MH; Kamada N; Kim YG; Núñez G
J Exp Med; 2012 Feb; 209(2):251-8. PubMed ID: 22291094
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression.
Xiao S; Jin H; Korn T; Liu SM; Oukka M; Lim B; Kuchroo VK
J Immunol; 2008 Aug; 181(4):2277-84. PubMed ID: 18684916
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-17A Serves a Priming Role in Autoimmunity by Recruiting IL-1β-Producing Myeloid Cells that Promote Pathogenic T Cells.
McGinley AM; Sutton CE; Edwards SC; Leane CM; DeCourcey J; Teijeiro A; Hamilton JA; Boon L; Djouder N; Mills KHG
Immunity; 2020 Feb; 52(2):342-356.e6. PubMed ID: 32023490
[TBL] [Abstract][Full Text] [Related]
16. Induction and molecular signature of pathogenic TH17 cells.
Lee Y; Awasthi A; Yosef N; Quintana FJ; Xiao S; Peters A; Wu C; Kleinewietfeld M; Kunder S; Hafler DA; Sobel RA; Regev A; Kuchroo VK
Nat Immunol; 2012 Oct; 13(10):991-9. PubMed ID: 22961052
[TBL] [Abstract][Full Text] [Related]
17. IL-21 is a central memory T cell-associated cytokine that inhibits the generation of pathogenic Th1/17 effector cells.
Kastirr I; Maglie S; Paroni M; Alfen JS; Nizzoli G; Sugliano E; Crosti MC; Moro M; Steckel B; Steinfelder S; Stölzel K; Romagnani C; Botti F; Caprioli F; Pagani M; Abrignani S; Geginat J
J Immunol; 2014 Oct; 193(7):3322-31. PubMed ID: 25172491
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.
Bettelli E; Carrier Y; Gao W; Korn T; Strom TB; Oukka M; Weiner HL; Kuchroo VK
Nature; 2006 May; 441(7090):235-8. PubMed ID: 16648838
[TBL] [Abstract][Full Text] [Related]
19. Excess IL-1 signaling enhances the development of Th17 cells by downregulating TGF-β-induced Foxp3 expression.
Ikeda S; Saijo S; Murayama MA; Shimizu K; Akitsu A; Iwakura Y
J Immunol; 2014 Feb; 192(4):1449-58. PubMed ID: 24431229
[TBL] [Abstract][Full Text] [Related]
20. Nuclear receptor NR4A2 orchestrates Th17 cell-mediated autoimmune inflammation via IL-21 signalling.
Raveney BJ; Oki S; Yamamura T
PLoS One; 2013; 8(2):e56595. PubMed ID: 23437182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
